Göm menyn

Publications for Lennart Krysander


Co-author map based on Web of Sciences articles 2007-

Journal Articles

Annika Håkansson, Bertil Gustafsson, Avni Abdiu, Lennart Krysander and Leif Håkansson
  Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy
  Cancer Immunology and Immunotherapy, 2003, 52(4), 249-254.
 Web of Science® Times Cited: 12

Monique R Bernsen, Toon Smetsers, Els van der Westerlo, Dirk Ruiter, Leif Håkansson, Bertil Gustafsson, Toin van Kuppevelt, Lennart Krysander, Björn Rettrup and Annika Håkansson
  Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma
  Cancer Immunology and Immunotherapy, 2003, 52(12), 780-783.
 Web of Science® Times Cited: 4

MR Bernsen, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, B Rettrup, D Ruiter and Annika Håkansson
  On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
  British Journal of Cancer, 2003, 88(3), 424-431.
 Web of Science® Times Cited: 30

Annika Håkansson, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, Björn Rettrup, Dirk Ruiter and Monique R Bernsen
  On the effect of biochemotherapy in metastatic malignant melanoma: An immunopathological evaluation
  Melanoma research, 2003, 13(4), 401-407.
 Web of Science® Times Cited: 6

Annika Håkansson, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, Björn Rettrup, Dirk Ruiter and Monique Bernsen
  Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28
  Cancer Immunology and Immunotherapy, 2002, 51(9), 499-504.
 Web of Science® Times Cited: 11

Annika Håkansson, Bertil Gustafsson, Lennart Krysander, B Hjelmqvist, B Rettrup and L Håkansson
  Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
  British Journal of Cancer, 2001, 85(12), 1871-1877.
 Web of Science® Times Cited: 23

G Cohn-Cedermark, LE Rutqvist, R Andersson, M Breivald, C Ingvar, H Johansson, PE Jonsson, Lennart Krysander, C Lindholm and U Ringborg
  Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm
  Cancer, 2000, 89(7), 1495-1501.
 Web of Science® Times Cited: 142

Annika Håkansson, Bertil Gustafsson, Lennart Krysander, B. Hjelmqvist, B. Rettrup and L. Håkansson
  Expression of ICAM-1 during IFN-alpha-based treatment of metastatic malignant melanoma: relation to tumour infiltrating mononuclear cells and regressive tumour changes.
  Journal of Interferon and Cytokine Research, 1999, 19, 171-177.

Annika Håkansson, Bertil Gustafsson, Lennart Krysander, Bengt Hjelmqvist, Björn Rettrup and Leif Håkansson
  On down-regulation of the immune response to metastatic malignant melanoma.
  Cancer Immunology and Immunotherapy, 1999, 48, 253-262.

 



Responsible for this page: Peter Berkesand
Last updated: 2017-02-21